PRPH

ProPhase Labs, Inc.

OTC · Pharmaceutical Preparations · Inc. DE · CIK 0000868278
$0.1000 0.00%
Vol
Inst. Holders4 funds
Inst. Value$24.3K
Inst. Activity1 buys / 0 sells
Exchange OTC·Sector Pharmaceutical Preparations·Inc. DE·CIK 0000868278·Prev Close $0.1000

Recent Activity

Inst.
VANGUARD GROUP INC — NEW
53,192 shares ($23.8K)
May 18, 2026 earnings_calendar
PRPH Q1 2026 Earnings Scheduled — 2026-05-18

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Feb 2024
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Feb 21, 2024 HC Wainwright & Co. REITERATE Buy → Buy
Nov 10, 2023 HC Wainwright & Co. MAINTAIN Buy → Buy
Aug 14, 2023 HC Wainwright & Co. REITERATE Buy → Buy
Jun 2, 2023 HC Wainwright & Co. REITERATE Buy → Buy
May 12, 2023 HC Wainwright & Co. MAINTAIN Buy → Buy

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$23.8KNEW
MORGAN STANLEY$411.00
BANK OF AMERICA CORP$51.00
WELLS FARGO & COMPANY/MN$10.00
4 institutional holders with $24.3K total value (54,248 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC53,192$23.8K98.1%NEW
2MORGAN STANLEY919$411.001.7%
3BANK OF AMERICA CORP /DE/114$51.000.2%
4WELLS FARGO & COMPANY/MN23$10.000.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
VANGUARD GROUP INCNEW53,192$23.8K2025-Q4

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Feb 2024): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
2 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 1 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Feb 21, 2024 HC Wainwright & Co. REITERATE Buy Buy
Nov 10, 2023 HC Wainwright & Co. MAINTAIN Buy Buy
Aug 14, 2023 HC Wainwright & Co. REITERATE Buy Buy
Jun 2, 2023 HC Wainwright & Co. REITERATE Buy Buy
May 12, 2023 HC Wainwright & Co. MAINTAIN Buy Buy
Mar 8, 2023 HC Wainwright & Co. REITERATE Buy
Feb 23, 2023 HC Wainwright & Co. REITERATE Buy
Feb 16, 2023 HC Wainwright & Co. REITERATE Buy
Feb 7, 2023 HC Wainwright & Co. REITERATE Buy
Nov 11, 2022 HC Wainwright & Co. MAINTAIN Buy
May 17, 2022 HC Wainwright & Co. MAINTAIN Buy
Mar 31, 2022 HC Wainwright & Co. MAINTAIN Buy
Jan 14, 2022 HC Wainwright & Co. MAINTAIN Buy
Dec 20, 2021 HC Wainwright & Co. INITIATE Buy
Oct 13, 2021 Dawson James DOWNGRADE Buy Neutral

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Mar 1, 20252410086%
Feb 1, 20252410086%
Jan 1, 20252410086%
Dec 1, 20242410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 18, 2026
earnings_calendar
PRPH Q1 2026 Earnings Scheduled — 2026-05-18
Apr 15, 2026
earnings_calendar
PRPH Q4 2025 Earnings After Market Close — 2026-04-15
Apr 6, 2026
earnings_calendar
PRPH Q4 2025 Earnings After Market Close — 2026-04-06
Mar 30, 2026
earnings_calendar
PRPH Q4 2025 Earnings After Market Close — 2026-03-30